Compounds > ro 24-5098
Page last updated: 2024-09-03

ro 24-5098 and 2,6-diaminopurine 2',3'-dideoxyriboside

ro 24-5098 has been researched along with 2,6-diaminopurine 2',3'-dideoxyriboside in 1 studies

Compound Research Comparison

Studies
(ro 24-5098)		Trials
(ro 24-5098)		Recent Studies (post-2010)
(ro 24-5098)		Studies
(2,6-diaminopurine 2',3'-dideoxyriboside)		Trials
(2,6-diaminopurine 2',3'-dideoxyriboside)		Recent Studies (post-2010) (2,6-diaminopurine 2',3'-dideoxyriboside)
8001100

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, BD; Broder, S; Huryn, DM; Mitsuya, H; Sim, I; Sluboski, BC; Tam, SY; Weigele, M1

Other Studies

1 other study(ies) available for ro 24-5098 and 2,6-diaminopurine 2',3'-dideoxyriboside

ArticleYear
Synthesis and anti-HIV activity of isonucleosides.
    Journal of medicinal chemistry, 1992, Jun-26, Volume: 35, Issue:13

    Topics: Antiviral Agents; Cells, Cultured; Chromatography, Liquid; Dideoxynucleosides; Drug Stability; Gene Products, gag; HIV-1; Humans; Isomerism; Monocytes; Spectrum Analysis; Virus Replication

1992